Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses to 1- or 2-dose 9-valent HPV Vaccination in Healthy Adults
NCT06799494Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Aug 2025
- Primary completion
- Sep 2028
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Emory University. Started Aug 2025; status: recruiting.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT06799494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799494.